In the ageing eye, vitreous body liquefaction (syneresis) and collapse A landmark scanning electron microscopic study of autopsy eyes with spontaneous PVD found remnants of vitreous cortex in the foveal area.
area and the margin of the 1,500µm fovea are sites of firm vitreoretinal adhesion. 13 Vitreous traction forces resulting from perifoveal PVD with a small vitreofoveolar adhesion (500µm or less) by imparting greater tractional stress, may cause localised cystoid foveal thickening, or one of several macular hole conditions. Lower tractional stress associated with larger adhesion zones may cause a separate group of macular disorders such as VMTS, traction diabetic macular oedema and myopic traction maculopathy, or exacerbate an age-related macular degeneration (AMD). 2, 11 Spaide found a statistically significant correlation between smaller diameters of vitreous attachment and the amount of foveal deformation in early macular hole stages. 14 The hypothesis is that the tractional stress (force per unit area) acting on the fovea increases with decreasing area of vitreous attachment.
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In epiretinal membranes (ERMs), there is significant variability in the size, number and presence or absence of vitreomacular attachments. 2, 15, 16 Ultrastructural studies suggest that ERMs develop from cortical vitreous remnants left on the retinal surface after PVD and play an important role in the pathogenesis of traction maculopathies. In the last few years, OCT techniques have evolved to spectral-domain OCT (SD-OCT), which features a higher speed and improved resolution, presenting an axial resolution of 3-7µm and a scanning speed of up to 40,000 A-scans per second in commercially available systems. [38] [39] [40] Most importantly, these advanced OCT systems are based on a raster scanning method and provide a 3D reconstruction of the entire macular region, substantially contributing to a better understanding and spatial perception of the pathophysiologic features of the vitreoretinal interface and helping surgical planning as it reveals the manner and direction of ERM traction on the retina. [41] [42] [43] Recently, in an observational, cross-sectional study, 44 
Therapy
The current standard of care of vitreomacular interface pathologies is vitrectomy and membrane peeling -a procedure that is thought to relieve epiretinal traction -followed by regeneration of the retinal architecture (see Figure 3) and recovery of visual function. 45 A complete vitrectomy combined with the induction of a posterior hyaloid detachment releases both static, trampoline-like traction anteriorly to the foveola due to the elastic properties of the hyaloid and the dynamic vitreous traction forces generated during ocular rotations in the early stage of PVD. 46 Then, a careful removal of the ERM and ILM is performed.
Since the advent of vitrectomy in the early 1970s, there has been a continuing evolution in vitrectomy techniques, indications and instrumentation. 47, 48 Three-port system pars plana vitrectomy (PPV) remained the standard of care for over 30 years. Twenty-gauge (0.89mm) vitrectomy has been both well tolerated and effective, with high rates of successful outcomes and low rates of complications. Over the last few years, with the introduction of 25-gauge (0.50mm) and 23-gauge (0.72mm) instruments, there has been another major shift toward transconjunctival microincisional vitrectomy surgery (MIVS).
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The advantages of a transconjunctival, sutureless approach include increased patient comfort, decreased corneal astigmatism and decreased operative times. [53] [54] [55] [56] In addition, there is less conjunctival scarring, which may benefit patients who have had multiple previous surgeries, or where preserving the conjunctiva is paramount (as in glaucoma patients who may require filtering surgery). 57 The advantages must be weighed against the potential drawbacks of post-operative hypotony and a possible increased risk of endophthalmitis. 58 As instrumentation for MIVS continues to evolve, the indications for transconjunctival sutureless vitrectomy continue to increase, with low rates of complications. 57 The concept of 'minimally invasive vitreous surgery' has to be referred not only to the size of the pars plana sclerotomy entry site, but also to what extent the vitreous gel needs to be vitrectomised [59] [60] [61] and the number of sclerotomies.
62-64
Sakaguchi et al. 65 have further reduced the size of two sclerotomies to accommodate 27-G micro-instruments to perform a non-vitrectomising technique, only for epiretinal membranes.
More recently, Gualtieri 66 reported preliminary results of a pilot study of minimally invasive vitrectomy through one-port pars plana sclerotomy, by 25-G instruments for selected vitreous, macular and vitreomacular interface disorders.
Since 2000, the so-called 'chromovitrectomy' has become a common approach among vitreoretinal surgeons. [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] It concerns the use of vital dyes or crystals to improve the visualisation of intraocular tissues, thereby improving the surgical outcome. In macular hole surgery, after vitrectomy procedure, indocyanine green (ICG) was injected in the vitreous cavity over the macular area to stain the ILM and facilitate membrane peeling. 67, 68, 70 Trypan blue was used as a helpful tool to identify the several types of ERM, 69 while the intravitreal triamcinolone acetonide has been very useful for improvement of vitreous identification. 71 Recently, several other dyes, including infracyanine green, patent blue, bromophenol blue and brilliant blue have been proposed as possible tools in chromovitrectomy. [72] [73] [74] [75] [76] [77] [78] [79] [80] Although intra-operative application of vital dyes has facilitated surgical techniques and outcomes in recent years, controversy still remains Diagnosing and Treating Vitreomacular Adhesion The ability to treat and even prevent the complications of early-stage PVD will expand as safe and effective pharmacological methods for inducing PVD become available. 10 The goals of pharmacological vitreolysis are to induce liquefaction of the vitreal gel and promote complete dehiscence of the vitreous from the retina. 83 The migration toward 25- Results from a phase II study evaluating the safety and efficacy of intravitreal microplasmin in facilitating the creation of total PVD before vitrectomy are intriguing and warrant further investigation.
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Conclusion
In conclusion, the improvement of diagnostic tools, especially OCT, 
